Krauss D - Search Results

1

Virtual reality for assessing stereopsis performance and eye characteristics in Post-COVID.

Mehringer W, Stoeve M, Krauss D, Ring M, Steussloff F, Güttes M, Zott J, Hohberger B, Michelson G, Eskofier B. Mehringer W, et al. Among authors: krauss d. Sci Rep. 2023 Aug 13;13(1):13167. doi: 10.1038/s41598-023-40263-w. Sci Rep. 2023. PMID: 37574496 Free PMC article.

2

Author Correction: Virtual reality for assessing stereopsis performance and eye characteristics in Post-COVID.

Mehringer W, Stoeve M, Krauss D, Ring M, Steussloff F, Güttes M, Zott J, Hohberger B, Michelson G, Eskofier B. Mehringer W, et al. Among authors: krauss d. Sci Rep. 2023 Sep 28;13(1):16307. doi: 10.1038/s41598-023-43373-7. Sci Rep. 2023. PMID: 37770537 Free PMC article. No abstract available.

3

21 Gy single fraction prostate HDR brachytherapy: 5-year results of a single institution prospective pilot study.

Salari K, Hazy AJ, Ye H, Sebastian E, Limbacher A, Johnson M, Mitchell B, Thompson AB, Seymour ZA, Nandalur SR, Krauss DJ. Salari K, et al. Among authors: krauss dj. Brachytherapy. 2024 Mar 20:S1538-4721(24)00038-2. doi: 10.1016/j.brachy.2024.02.005. Online ahead of print. Brachytherapy. 2024. PMID: 38514368

4

Prostatic Urethral Length on MRI Potentially Predicts Late Genitourinary Toxicity After Prostate Cancer Radiation.

Lee J, Nandalur S, Hazy A, Al-Katib S, Kim K, Ye H, Kolderman N, Dhaliwal A, Krauss D, Quinn T, Marvin K, Nandalur KR. Lee J, et al. Among authors: krauss d. Acad Radiol. 2024 May;31(5):1950-1958. doi: 10.1016/j.acra.2023.09.004. Epub 2023 Oct 17. Acad Radiol. 2024. PMID: 37858506

5

Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel disease.

Mödl B, Awad M, Zwolanek D, Scharf I, Schwertner K, Milovanovic D, Moser D, Schmidt K, Pjevac P, Hausmann B, Krauß D, Mohr T, Svinka J, Kenner L, Casanova E, Timelthaler G, Sibilia M, Krieger S, Eferl R. Mödl B, et al. Among authors: krauss d. EMBO Rep. 2023 Oct 9;24(10):e57084. doi: 10.15252/embr.202357084. Epub 2023 Sep 11. EMBO Rep. 2023. PMID: 37691494 Free PMC article.

6

Interaction Between Determinants Governing Urine Volume in Patients With ADPKD on Tolvaptan and its Impact on Quality of Life.

Todorova P, Arjune S, Hendrix C, Oehm S, Schmidt J, Krauß D, Burkert K, Burst VR, Benzing T, Boehm V, Grundmann F, Müller RU. Todorova P, et al. Among authors: krauss d. Kidney Int Rep. 2023 May 20;8(8):1616-1626. doi: 10.1016/j.ekir.2023.05.011. eCollection 2023 Aug. Kidney Int Rep. 2023. PMID: 37547529 Free PMC article.

7

Risk assessment of child-pornography-exclusive offenders.

Scurich N, Krauss DA. Scurich N, et al. Among authors: krauss da. Law Hum Behav. 2023 Aug;47(4):499-509. doi: 10.1037/lhb0000537. Law Hum Behav. 2023. PMID: 37471014

8

High-dose-rate brachytherapy as monotherapy versus as boost in unfavorable intermediate-risk localized prostate cancer: A matched-pair analysis.

Willen BD, Salari K, Zureick AH, Lang D, Ye H, Marvin K, Nandalur SR, Krauss DJ. Willen BD, et al. Among authors: krauss dj. Brachytherapy. 2023 Sep-Oct;22(5):571-579. doi: 10.1016/j.brachy.2023.05.002. Epub 2023 Jun 14. Brachytherapy. 2023. PMID: 37328337

9

FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice.

Malik B, Vokic I, Mohr T, Poppelaars M, Holcmann M, Novoszel P, Timelthaler G, Lendl T, Krauss D, Elling U, Mildner M, Penninger JM, Petzelbauer P, Sibilia M, Csiszar A. Malik B, et al. Among authors: krauss d. EMBO Mol Med. 2023 Jul 10;15(7):e16758. doi: 10.15252/emmm.202216758. Epub 2023 May 25. EMBO Mol Med. 2023. PMID: 37226685 Free PMC article.

10

Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial.

Krauss DJ, Karrison T, Martinez AA, Morton G, Yan D, Bruner DW, Movsas B, Elshaikh M, Citrin D, Hershatter B, Michalski JM, Efstathiou JA, Currey A, Kavadi VS, Cury FL, Lock M, Raben A, Seaward SA, El-Gayed A, Rodgers JP, Sandler HM. Krauss DJ, et al. J Clin Oncol. 2023 Jun 10;41(17):3203-3216. doi: 10.1200/JCO.22.02390. Epub 2023 Apr 27. J Clin Oncol. 2023. PMID: 37104748

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page